Riskpilot← Back to searchSign inGet full accessSTUDIO NINE AB
ABActiveOrg 5592652886Tullaregatan 10Other human health activities n.e.c. · NACE 8699Est. 20205-9 employees
Revenue 2024
SEK 2,4M
+6% vs 2023
EBITDA margin
-1.2%
-136% vs 2023
Equity ratio
23.8%
Financial strength
Net profit 2024
SEK -51K
-199% vs 2023
| Revenue | SEK 2,4M | +6% |
| EBITDA | SEK -29K | -136% |
| Net profit | SEK -51K | -199% |
| Total assets | SEK 373K | -5% |
| Equity | SEK 89K | -36% |
| Employees | — | — |
Legal name
STUDIO NINE AB
Org number
5592652886
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
30 juli 2020
Share capital
SEK 25 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva estetiska och medicinska skönhetsbehandlingar, hudvård, injektionsbehandlingar, laser- och maskinbehandlingar, försäljning av skönhets- och hudvårdsprodukter samt därmed förenlig verksamhet.
Address
Tullaregatan 10
Email
nina.rezniqi@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 1 280 | 1 855 | 2 228 | 2 370 |
| Staff expenses | — | −940 | −877 | −1 098 |
| EBITDA | 34 | 53 | 79 | −29 |
| Depreciation & amort. | −0 | −0 | −9 | −21 |
| EBIT | 34 | 53 | 70 | −50 |
| Net financials | — | −1 | −0 | −1 |
| Profit before tax | 34 | 52 | 70 | −51 |
| Tax | −9 | −13 | −18 | — |
| Net profit | 25 | 38 | 52 | −51 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 337 | 321 | 394 | 373 |
| Equity | 50 | 88 | 140 | 89 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 288 | 233 | 254 | 284 |
| Total debt | 288 | 233 | 254 | 284 |
EBITDA margin
-1.2%
This company
15.8%
Market median
-108% vs market
20212024
Equity ratio
23.8%
This company
38.2%
Market median
-38% vs market
20212024
Return on equity
-57.2%
This company
18.4%
Market median
-411% vs market
20212024
Net profit margin
-2.1%
This company
8.1%
Market median
-126% vs market
20212024
Asset turnover
6.36×
This company
1.12×
Market median
+468% vs market
20212024
Debt / equity
3.19×
This company
0.62×
Market median
-415% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Former (5) | ||
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of STUDIO NINE AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Nina Rezniqi | Board of Directors | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Ideal Rezniqi | Deputy Board Member | 0 companies |
| Maja Lejon | Deputy Board Member | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |